![]() |
市场调查报告书
商品编码
1729538
日本神经学设备市场报告(按设备类型(脑脊髓液管理设备、介入性神经病学设备、神经外科设备、神经刺激设备等)和地区)2025 年至 2033 年Japan Neurology Devices Market Report by Type of Device (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices, Neurostimulation Devices, and Others), and Region 2025-2033 |
2024 年,日本神经病学设备市场规模达 8.52 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 13.14 亿美元,2025-2033 年期间的成长率 (CAGR) 为 4.9%。神经系统疾病盛行率的上升以及技术的不断进步是推动市场成长的主要动力。
神经病学是医学科学的一个分支,致力于解决神经系统内的疾病和异常。神经病学领域通常使用各种类型的仪器。例如,骶神经刺激装置是透过向位于背部下部的指定骶神经传输电讯号来运作。相反,脑脊髓液管理装置负责调节脑脊髓液的流动并排出脑中多余的液体。类似地,介入设备利用放射技术和导管来诊断影响中枢神经系统的疾病,而深部脑刺激设备则透过植入向大脑特定目标区域发射电脉衝的设备来协助医疗程序。这些设备在解决复杂疾病方面发挥关键作用。因此,它们被广泛应用于治疗多种神经系统疾病,包括但不限于强迫症、帕金森氏症、肌张力失调、慢性疼痛、特发性震颤和重度忧郁症。
日本神经病学市场主要受到医疗保健行业的大幅增长的推动。此外,神经系统疾病盛行率的不断上升极大地推动了对这些产品的需求,从而对区域市场产生了积极影响。老年人口的增加以及老年人中风等神经血管疾病发生率的增加也加速了神经病学设备的普及,从而促进了市场的成长。此外,神经病学设备的技术不断进步以及对微创(MI)手术的广泛需求也是促进日本成长的重要因素。推动市场扩张的其他因素包括医疗保健支出的增加、全球医疗器材製造商的大量投资以及神经治疗领域的广泛研发 (R&D) 活动。此外,预计医疗产业的众多技术进步将在预测期内推动市场成长。
市场研究报告也对市场竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。
Japan neurology devices market size reached USD 852.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,314.0 Million by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The rising prevalence of neurological disorders, along with the continual technological advancements, is primarily driving the market growth.
Neurology is a branch of medical science dedicated to addressing conditions and irregularities within the nervous system. Various categories of instruments are commonly employed in the field of neurology. For instance, sacral nerve stimulation apparatus operates by transmitting electrical signals to the designated sacral nerves situated in the lower part of the back. Conversely, devices for cerebrospinal fluid management are responsible for regulating the flow of cerebrospinal fluid and draining any excess fluid from the brain. In a similar vein, interventional equipment utilizes radiological techniques and catheters to diagnose medical conditions affecting the central nervous system, while deep brain stimulation devices assist in medical procedures by implanting a device that emits electrical impulses to specific target regions in the brain. These devices play a pivotal role in addressing intricate disorders. Consequently, they are extensively employed in the treatment of a multitude of neurological ailments, including but not limited to obsessive-compulsive disorder, Parkinson's disease, dystonia, chronic pain, essential tremor, and major depression.
The neurology market in Japan is primarily being fueled by substantial growth within the healthcare sector. Furthermore, the increasing prevalence of neurological disorders is substantially driving the demand for these products, which is positively influencing the regional market. The rising elderly population and the growing occurrences of neurovascular conditions, such as strokes, among older individuals are also accelerating the adoption of neurology devices, thereby bolstering the market growth. Additionally, continuous technological advancements in neurology devices and the widespread demand for minimally invasive (MI) surgical procedures are also serving as significant factors that encourage growth in Japan. Other factors that are giving a boost to market expansion include the increasing healthcare expenditure, substantial investments by global medical device manufacturers, and extensive research and development (R&D) activities in the field of neurotherapy. Furthermore, numerous technological advancements in the medical industry are anticipated to fuel the market growth over the forecasted period.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.